BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9212369)

  • 1. [Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection].
    Chimura T
    Jpn J Antibiot; 1997 May; 50(5):479-84. PubMed ID: 9212369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field].
    Chimura T
    Jpn J Antibiot; 2002 Apr; 55(2):196-202. PubMed ID: 12071097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of the detection of serum specific IgA and IgG antibodies to Chlamydia trachomatis in the epidemiological survey, diagnosis and therapeutic effect on chlamydial infection in women].
    Utsuno S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):763-70. PubMed ID: 1890354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of serum specific IgA antibody to Chlamydia trachomatis in the diagnosis and treatment of chlamydial infection in female genital tract].
    Kasamatsu T; Sugase M; Yoshikawa H; Kawana T; Mizuno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):479-86. PubMed ID: 2664040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequate levofloxacin treatment schedules for uterine cervicitis caused by Chlamydia trachomatis.
    Mikamo H; Sato Y; Hayasaki Y; Hua YX; Tamaya T
    Chemotherapy; 2000; 46(2):150-2. PubMed ID: 10671767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis].
    Mikamo H; Yamagishi Y; Takahashi K; Izumi K; Hoshina S; Nakabe K; Fujiwara M; Yoshimura M; Ando Y; Kurashima M; Kinoshita C; Yoshioka M
    Jpn J Antibiot; 2011 Aug; 64(4):217-29. PubMed ID: 22066346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of levofloxacin once-a-day therapy on uterine cervicitis].
    Mikamo H; Sato Y; Hayasaki Y; Tamaya T; Yamada Y; Ito K; Izumi K; Kawazoe K
    Jpn J Antibiot; 1999 Jul; 52(7):511-6. PubMed ID: 10516931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic efficacy of chlamydial antibodies in cervical secretions from pregnant women and adolescent girls.
    Thejls H; Rahm VA; Gnarpe J; Gnarpe H
    Genitourin Med; 1995 Dec; 71(6):370-4. PubMed ID: 8566976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection.
    McCormack WM; Martin DH; Hook EW; Jones RB
    Infect Dis Obstet Gynecol; 1998; 6(3):109-15. PubMed ID: 9785106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic pregnancy and antibodies to Chlamydia trachomatis.
    Svensson L; Mårdh PA; Ahlgren M; Nordenskjöld F
    Fertil Steril; 1985 Sep; 44(3):313-7. PubMed ID: 4029419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis].
    Kumamoto Y; Sakai S; Hirose T; Tsunekawa T; Machida T; Kiyota H; Okazaki T; Kishi H; Higashihara E; Aso Y
    Jpn J Antibiot; 1988 Oct; 41(10):1445-79. PubMed ID: 3144614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of Chlamydia trachomatis-specific IgA, IgG antibody with EIA method].
    Satoh T; Kumamoto Y; Hirose T; Nishimura M; Koroku M; Matsumoto A; Miyashita N; Gohro T; Ikegaki S; Koroku Y
    Kansenshogaku Zasshi; 1994 Jan; 68(1):116-26. PubMed ID: 8138667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of chlamydial infection on the reproductive function in women with cervicitis].
    Grueva E; Borisov I
    Akush Ginekol (Sofiia); 2006; 45(6):35-9. PubMed ID: 17168481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the assay technique for detection of anti-chlamydial IgA and IgG antibodies in PID patients].
    Yasuda J; Higashi Y; Tada Y; Fujiwara Y; Kashiwagi N; Kashiwagi T; Yamamoto T; Honjo H
    Kansenshogaku Zasshi; 1997 Mar; 71(3):241-7. PubMed ID: 9128009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the monomeric IgA to polymeric IgA ratio in specific IgA antibodies for Chlamydia trachomatis--clinical studies in chlamydial urogenital infections].
    Hayashi K; Kumamoto Y; Hirane T
    Kansenshogaku Zasshi; 1991 Jan; 65(1):7-18. PubMed ID: 2066593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of levofloxacin in cervical mucus and its clinical effects on cervicitis.
    Chimura T; Arai M; Onuma Y; Oda T; Kawagoe S; Kunii K; Saito T; Saito N; Sato F; Numazaki M; Matsuo M; Murayama K; Morizaki N
    Jpn J Antibiot; 1997 Nov; 50(11):871-7. PubMed ID: 9651605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host immune response in chlamydial cervicitis.
    Mittal A; Kapur S; Gupta S
    Br J Biomed Sci; 1996 Sep; 53(3):214-20. PubMed ID: 8914349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis.
    Mikamo H; Sato Y; Hayasaki Y; Tamaya T
    Chemotherapy; 1999; 45(5):396-8. PubMed ID: 10473928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydial cervicitis: complications and new treatment options.
    Majeroni BA
    Am Fam Physician; 1994 Jun; 49(8):1825-9, 1832. PubMed ID: 8203320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and treatment of pharyngeal Chlamydia trachomatis infections].
    Mikamo H; Tamaya T; Tanaka K; Watanabe K
    Jpn J Antibiot; 2006 Feb; 59(1):35-40. PubMed ID: 16673581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.